PMS-Irbesartan Product Recall (2021-05-25)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
PMS-Irbesartan 75 mg Tablet
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 617492, 624634, 630661 | B. PMS-Irbesartan 150 mg Tablet | - Recalling Firm
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
| DIN 02317079 | Tablet | Irbesartan 150 mg |
| 617466, 617467, 617468, 620272, 622195, 624738 | PMS-Irbesartan 75 mg Tablet | - Recalling Firm
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
| DIN 02317060 | Tablet | Irbesartan 75 mg |
-
PMS-Irbesartan 75 mg Tablet
-
PMS-Irbesartan 150 mg Tablet
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.